Cipla Ltd 500087
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₹1,656.00
- Day Range
- ₹1,577.80–1,650.05
- 52-Week Range
- ₹1,132.00–1,684.95
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹1.31 Tril
- Volume/Avg
- 58,979 / 37,384
Key Statistics
- Price/Earnings (Normalized)
- 30.49
- Price/Sales
- 5.08
- Dividend Yield (Trailing)
- 0.80%
- Dividend Yield (Forward)
- 0.80%
- Total Yield
- 0.80%
Company Profile
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 40,993
- Website
- https://www.cipla.com
Comparables
Valuation
|
Metric
|
500087
|
543434
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.49 | 33.42 | 30.47 |
Price/Book Value | 4.92 | 5.62 | 3.70 |
Price/Sales | 5.08 | 7.82 | 1.97 |
Price/Cash Flow | 26.90 | 35.27 | 21.11 |
Price/Earnings
500087
543434
524348
Financial Strength
|
Metric
|
500087
|
543434
|
524348
|
|---|---|---|---|
Quick Ratio | 2.47 | 2.47 | 0.91 |
Current Ratio | 3.71 | 5.17 | 1.66 |
Interest Coverage | 79.68 | 51.09 | 7.34 |
Quick Ratio
500087
543434
524348
Profitability
|
Metric
|
500087
|
543434
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
500087
543434
524348
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Hmnfxhxb | Yhvd | $798.8 Bil | |||
| Johnson & Johnson
JNJ
| Mqgjhmbl | Lwks | $385.9 Bil | |||
| AbbVie Inc
ABBV
| Ghlxjsjgm | Rytpv | $343.2 Bil | |||
| Merck & Co Inc
MRK
| Ccxnvmgl | Bzwy | $278.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Xckcsjksk | Rvl | $244.4 Bil | |||
| AstraZeneca PLC ADR
AZN
| Xzjkyzcxkq | Rzfcc | $238.9 Bil | |||
| Novartis AG ADR
NVS
| Nnqvxkqkz | Gnhv | $232.2 Bil | |||
| Amgen Inc
AMGN
| Pfyvhczgw | Ffdh | $171.8 Bil | |||
| Pfizer Inc
PFE
| Cpvbvfhx | Ykzd | $162.0 Bil | |||
| Sanofi SA ADR
SNY
| Spwrfxbq | Pghwf | $140.7 Bil |
United States